-
公开(公告)号：EP3108255B1
公开(公告)日：2020-08-12
申请号：EP15704806.7
申请日：2015-02-18
申请人： INSERM (Institut National de la Santé et de la Recherche Médicale) , Université Paris Descartes , Fondation Imagine , Assistance Publique-Hôpitaux de Paris (APHP) , Centre National de la Recherche Scientifique (C.N.R.S.) , Université Grenoble Alpes , Commissariat à l'Energie Atomique et aux Energies Alternatives , Université de Bourgogne
发明人： BELAID-CHOUCAIR, Zakia , HERMINE, Olivier , GARRIDO-FLEURY, Carmen , COCHET, Claude , FILHOL-COCHET, Odile , SEIGNEURIC, Renaud
IPC分类号： G01N33/574 , G01N33/50
-
2.发明公开
公开(公告)号：EP3155431A1
公开(公告)日：2017-04-19
申请号：EP15728015.7
申请日：2015-06-12
IPC分类号： G01N33/574
CPC分类号： G01N33/57488 , A61K38/08 , G01N2333/47
摘要： The invention relates to methods for diagnosing cancer and determining the responsiveness to chemotherapyin a subject based on the detection of HSP70-expressing exosomes in a bodily fluid sample obtained from said subject. The invention also relates to methods for treating cancer and in particular methods for restoring or enhancing the anti-tumor immune response in a patient in need thereof by inhibiting the activation MDSC as well as methods for inhibiting or reducing HSP70-expressing exosomes-mediated tumor resistance against a chemotherapeutic agent and therefore methods for restoring or enhancing the efficacy of said chemotherapeutic agent.
摘要翻译： 本发明涉及用于诊断癌症和确定性采矿的响应到chemotherapyin基于表达从所述受试者获得的体液样品中的外泌体的检测HSP70的受试者的方法。 因此，本发明涉及的方法用于治疗癌症和在用于恢复或通过抑制活化MDSC以及用于抑制或减少HSP70表达的方法提高在有需要的患者的抗肿瘤免疫应答的具体方法的外来体介导的肿瘤抗性 对化学治疗剂和用于恢复或增强化疗剂的功效的方法THEREFORE所述。
-
公开(公告)号：EP3353196A1
公开(公告)日：2018-08-01
申请号：EP16775121.3
申请日：2016-09-21
申请人： INSERM (Institut National de la Santé et de la Recherche Médicale) , Fondation Imagine , Assistance Publique-Hôpitaux de Paris (APHP) , Université Paris Descartes , Centre National de la Recherche Scientifique (CNRS) , Université de Bourgogne , CNAM-CONSERVATOIRE NATIONAL DES ARTS ET METIERS
发明人： BELAID-CHOUCAIR, Zakia , HERMINE, Olivier , MONTES, Matthieu , GARRIDO-FLEURY, Carmen , SEIGNEURIC, Renaud , MARCION, Guillaume
IPC分类号： C07K14/575 , C07K14/72 , C07K14/705
CPC分类号： C07K14/475 , A61K38/1866 , A61K39/3955 , A61K2039/505 , A61P35/00 , C07K14/5759 , C07K14/705 , C07K14/72 , C07K16/22 , C07K2317/76
摘要： The present invention relates to agents capable of inhibiting the binding between Leptin and Neuropilin-1 (NRP1) and uses thereof in the therapeutic field.
-
4.发明公开METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES MEDIATED BY THE NRP-1/OBR COMPLEX SIGNALING PATHWAY 审中-公开方法和药物组合物治疗由NRP-1 / OBR KOMPLEXSIGNALWEG介导的疾病
公开(公告)号：EP3108255A1
公开(公告)日：2016-12-28
申请号：EP15704806.7
申请日：2015-02-18
申请人： INSERM (Institut National de la Santé et de la Recherche Médicale) , Université Paris Descartes , Fondation Imagine , Assistance Publique-Hôpitaux de Paris (APHP) , Centre National de la Recherche Scientifique (C.N.R.S.) , Université Grenoble Alpes , Commissariat à l'Energie Atomique et aux Energies Alternatives , Université de Bourgogne
发明人： BELAID-CHOUCAIR, Zakia , HERMINE, Olivier , GARRIDO-FLEURY, Carmen , COCHET, Claude , FILHOL-COCHET, Odile , SEIGNEURIC, Renaud
IPC分类号： G01N33/574 , G01N33/50
摘要： The present invention relates to methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway. In particular, the present invention relates to a method for treating a disease selected from the group consisting of cancers, obesity and obesity related diseases, anorexia, autoimmune diseases and infectious diseases in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an antagonist of the NRP-1/OBR signaling pathway.
摘要翻译： 本发明涉及用于治疗疾病由NRP-1 / OBR复杂信号传导途径介导的疾病的方法和药物组合物。 特别地，本发明涉及一种用于治疗选自下组在有需要的受试者的癌症，肥胖症和肥胖症相关疾病，厌食，自身免疫性疾病和感染性疾病由......组成，其包括施用与治疗有效量的本发明的疾病 的NRP-1 / OBR信号传导途径的拮抗剂。
-
公开(公告)号：EP3198002B1
公开(公告)日：2020-09-09
申请号：EP15766181.0
申请日：2015-09-21
申请人： Université de Bourgogne , INRA , INSERM
-
公开(公告)号：EP3198002A1
公开(公告)日：2017-08-02
申请号：EP15766181.0
申请日：2015-09-21
申请人： Université de Bourgogne , INRA , INSERM
摘要： The present invention relates in particular to a method for the expression of a protein of interest by a bacterium, notable in that it comprises the culturing of a bacterium temporarily or continuously expressing an Hsp protein, in that said bacterium also comprises a nucleic acid sequence, encoding a protein of interest, under the control of a lac promoter and in that said bacterium is cultured in a medium which does not contain IPTG or a metabolized molecule in such a way as to automatically induce the induction of transcription from the lac promoter.
摘要翻译： 本发明特别涉及用于由细菌表达目的蛋白质的方法，其特征在于它包括暂时或连续表达Hsp蛋白质的细菌的培养，因为所述细菌还包含核酸序列， 在lac启动子的控制下编码感兴趣的蛋白质，并且所述细菌在不含有IPTG或代谢分子的培养基中以自动诱导从lac启动子诱导转录的方式培养。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.017 秒)
